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Extent of Preoperative False Lumen Thrombosis Does Not Influence
Long-Term Survival in Patients With Acute Type A Aortic Dissection
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Christoph A. Nienaber, MD; Toru Suzuki, MD; Rossella Fattori, MD; James B. Froehlich, MD; Stuart Hutchison, MD;
Thoralf M. Sundt, MD; James L. Januzzi, MD; Eric M. Isselbacher, MD; Daniel G. Montgomery, BS; Truls Myrmel, MD
Background-—Partial thrombosis of the false lumen has been related to aortic growth, reoperations, and death in the chronic
phase of type B and repaired type A aortic dissections. The impact of preoperative false lumen thrombosis has not been studied
previously. We used data from a contemporary, multinational database on aortic dissections to evaluate whether different degrees
of preoperative false lumen thrombosis influenced long-term prognosis.
Methods and Results-—We examined the records of 522 patients with surgically treated acute type A aortic dissections who
survived to discharge between 1996 and 2011. At the preoperative imaging, 414 (79.3%) patients had patent false lumens, 84
(16.1%) had partial thrombosis of the false lumen, and 24 (4.6%) had complete thrombosis of the false lumen. The annual median
(interquartile range) aortic growth rates were 0.5 (0.3 to 2.0) mm in the aortic arch, 2.0 (0.2 to 4.0) mm in the descending
thoracic aorta, and similar regardless of the degree of false lumen thrombosis. The overall 5-year survival rate was 84.7%, and it
was not influenced by false lumen thrombosis (P=0.86 by the log-rank test). Independent predictors of long-term mortality were
age >70 years (hazard ratio [HR], 2.34; 95% confidence interval [CI], 1.20 to 4.56, P=0.012) and postoperative cerebrovascular
accident, coma, and/or renal failure (HR, 2.62; 95% CI, 1.40 to 4.92, P=0.003).
Conclusions-—Patients with acute type A aortic dissection who survive to discharge have a favorable prognosis. Preoperative false
lumen thrombosis does not influence long-term mortality, reintervention rates, or aortic growth. ( J Am Heart Assoc. 2013;2:
e000112 doi: 10.1161/JAHA.113.000112)
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A cute type A aortic dissection (AAAD) is a challengingclinical emergency. Despite continuous improvements in
diagnosis, surgical treatment, and perioperative management,
the latest report from the International Registry of Acute
Aortic Dissection (IRAD) revealed an in-hospital surgical
mortality of 23.9%.1 This is similar to that found in a more
recent study from another large registry,2 while several
single-center series report mortality well below 10%.3–5
Patients who survive to discharge have reasonable interme-
diate and long-term survival rates.6,7
Several reports8–12 have indicated that patients with a
residual patent false lumen following an AAAD repair have an
increased risk of distal aortic enlargement and death. In
addition, the IRAD data have shown that in patients with acute
type B aortic dissections, partial thrombosis, more than a
completely patent false lumen, predicts a higher follow-up
mortality.13 As an extension of this observation, Song et al14
found that partial thrombosis of the false lumen after an
extensive Stanford type A (DeBakey type I) aortic dissection
repair is a predictor of aortic enlargement, aorta-related
procedures, and poor long-term survival. Different factors
have been proposed to account for this increased risk, and
one possible mechanism could be that the thrombus itself is a
risk factor by enhancing the coagulation system.15
In this context, we anticipated that a partial thrombosis of
the false lumen observed at the first hospitalization would
negatively affect the remodeling of the distal aorta, increase
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the need for reintervention, and negatively influence the
long-term survival of AAAD patients. To assess this hypoth-
esis, in the IRAD database, we analyzed the patients with




IRAD is a multinational registry that collects consecutive and
unselected cases of acute aortic dissection at 30 aortic
centers in 10 countries. Participation in the registry does not
per se imply treatment standardization. Further details about
the IRAD structure and data collection have been previously
published.16 The study was approved by the institutional
review board or ethics committee at each participating center.
Study Population
We screened the data records for all patients who were
enrolled in IRAD between January 1, 1996 and January 31,
2011. We identified 2380 patients with an AAAD, which was
defined as any nontraumatic dissection involving the ascend-
ing aorta and presenting within 14 days of symptom onset.
Iatrogenic dissections were included. The patients were
identified prospectively at presentation or retrospectively
from discharge diagnoses. The diagnosis was based on
imaging, intraoperative findings, and/or autopsy.
The patients who were exclusively managed medically, had
intramural hematomas, died during the index hospitalization,
or for whom follow-up or information on false lumen status
was lacking were excluded from the analysis (Figure 1). Our
final study population included 522 patients. Of these
patients, 414 (79.3%) had a patent, 84 (16.1%) a partially
thrombosed, and 24 (4.6%) a completely thrombosed false
lumen.
Data Collection
A standardized form with 290 variables was used at all IRAD
centers to describe the index hospital stay. This form included
patient demographics, past medical histories, presenting
symptoms, physical findings, imaging results, treatments,
and outcomes (including complications and mortality).
All of the patients underwent computed tomography,
magnetic resonance imaging, angiography, and/or echocar-
diography. The false lumen was classified as patent when flow
was present without evidence of thrombus at any level of the
aorta, as partially thrombosed when both flow and thrombus
were present, and completely thrombosed in the absence of
flow in the false lumen at any aortic level. Intramural
hematoma was defined as an aortic wall hematoma without
an intimal flap or tear on any imaging study. The distinction
between an intramural hematoma and a classic double-barrel
dissection with complete thrombosis of the false lumen was
determined by experts at each IRAD center.
Follow-up data were obtained annually for up to 5 years
using a standardized form to record clinical variables, imaging
data, reoperations (including endovascular and/or open
repair), and mortality.
Aortic Growth Analysis
The growth rate was calculated for the aortic arch and the
descending thoracic aorta. Aortic size was measured as the
largest transversal diameter perpendicular to the flow axis for
each segment. Patients who underwent arch replacement at
the index hospitalization were only included in the growth
calculations for the descending thoracic aorta. For patients
who underwent reintervention during follow-up, the latest
diameter measure before reintervention was used. The growth
rate was calculated as the difference between the most
recent diameter measure and the diameter at the index
hospitalization at the same aortic level, divided by the time
interval between the 2 measurements and expressed as
millimeters per year.
Figure 1. Study inclusion flow-chart. IRAD indicates International
Registry of Acute Aortic Dissection.
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Based on preoperative imaging at the index hospitalization,
the patients were stratified into 3 groups according to the
status of the false lumen: patent, partial thrombosis, and
complete thrombosis. The clinical characteristics of each
group are presented as frequencies and percentages for the
categorical variables and as meanstandard deviation (SD)
for the continuous variables. In cases of skewed distributions,
the continuous variables are presented as the median and
interquartile range (Q1 to Q3, the range between the 25th and
the 75th percentile). For categorical variables, between-group
differences were analyzed using the chi-squared or 2-sided
Fisher’s exact test, as appropriate. Continuous variables were
compared with an analysis of variance or a Kruskal–Wallis test
for data with skewed distributions. Missing data were not
defaulted to negative and denominators reflect only those
cases reported.
Univariate associations between clinical variables and
mortality were calculated using a Cox regression analysis.
Independent predictors of mortality were determined using a
stepwise Cox proportional-hazards analysis. The initial model
used variables with a P value of <0.15 in univariate testing
and also included false lumen status. A backward stepwise
selection of variables (after adjusting for sex and age) was
performed sequentially with a default value for inclusion set at
P<0.05.
Kaplan–Meier curves were created for the overall patient
cohort and stratified according to the false lumen status.
Curves were created for survival and for freedom from major
adverse events (all-cause mortality, aortic rupture, and
reoperation [including endovascular repair]). Between-group
differences in survival and freedom from major adverse events
were analyzed using the log-rank test.
All data analyses were performed using SPSS version 20
for Windows (SPSS Inc).
Results
Baseline Characteristics, Imaging, Treatment, and
Complications
The mean age (SD) of the 522 patients was 57.913.6
years, and 19.6% were aged >70 years (Table 1). The majority
of patients (74.9%) were male and had a history of hyperten-
sion (70.9%). Other common comorbidities were atheroscle-
rosis (19.1%), previous aortic aneurysm (11.7%), previous
open-heart surgery (8.8%), and cardiac catheterization or
percutaneous coronary intervention (7.8%). Marfan syndrome
was present in 5.8% of the patients, and 30.0% were current
smokers. Diabetes mellitus was rare in this patient cohort
(4.9%), as were chronic renal insufficiency (3.6%) and chronic
obstructive pulmonary disease (4.3%).
Almost a quarter of patients presented with hypotension,
shock, or cardiac tamponade. Chest pain was common
(85.3%); 15.0% of the patients presented with neurologic
deficits, and 28.9% had a pulse deficit.
The mean number (SD) of imaging studies per patient
was 1.80.7, with a median (Q1 to Q3) number of studies of
2.0 (1.0 to 3.0). The most frequent procedure was computed
tomography, which was performed in 81.0% of the patients,
and 78.6% underwent a trans-esophageal echocardiography.
Arch vessel involvement occurred in 40.3% of the patients.
About one-third of the dissections were confined to the
ascending aorta and aortic arch.
Complete arch replacement was performed in 12.3% of
cases, and the aortic valve was replaced in 29.9% of patients
(Table 2). Deliberate interruption of systemic perfusion was
used in 86.0%, with a median (Q1 to Q3) circulatory arrest
time of 44 (28 to 97) minutes.
Neurologic complications occurred in one quarter of the
patients, acute renal failure in 19.3%, and limb ischemia in
13.4%. Mesenteric ischemia was rare, occurring in only 3.2%
of patients.
Clinical Differences According to Preoperative
False Lumen Status
Patients with a patent false lumen were on average 3 years
younger than those with a partially thrombosed false lumen
and 6 years younger than those with complete false lumen
thrombosis. There were no differences with regard to previous
medical history, presenting symptoms, or clinical findings.
Patients with a patent false lumen had fewer imaging studies
per patient, with a mean (SD) of 1.70.6, versus 2.00.7
for those with partial thrombosis and 2.00.8 for those with
complete thrombosis (P=0.006). Computed tomography was
performed more frequently in the patients with partial
thrombosis of the false lumen (90.5%) compared to the
patients with complete patency or complete thrombosis of
the false lumen (79.4% or 75.0%, respectively, P=0.034).
The distal extension of the dissection was similar between the
groups; however, extension merely to the aortic arch occurred
more frequently in the partial thrombosis and complete
thrombosis groups than in the patent false lumen group
(31.8%, 37.5% and 17.1%, respectively, P=0.005). The surgical
strategy did not differ between the groups.
Aortic Growth and Long-Term Outcome
The median aortic growth rate (Q1 to Q3) was 0.5 (0.3
to 2.0) mm/year in the aortic arch and 2.0 (0.2 to 4.0)
mm/year in the descending thoracic aorta (Table 3). Aortic
growth was similar regardless of the degree of preoperative
false lumen thrombosis.
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Table 1. Patient Characteristics Stratified by False Lumen Status
All Patients (n=522)







Age, meanSD 57.913.6 57.013.6 60.813.4 63.312.6 0.009*
Age ≥70 years, no./total no. (%) 102/521 (19.6) 73/413 (17.7) 20/84 (23.8) 9/24 (37.5) 0.036
Female gender, no./total no. (%) 131/522 (25.1) 96/414 (23.2) 26/84 (31.0) 9/24 (37.5) 0.12
Marfan syndrome, no./total no. (%) 30/514 (5.8) 25/407 (6.1) 4/83 (4.8) 1/24 (4.2) 0.93
Hypertension, no./total no. (%) 365/515 (70.9) 289/410 (70.5) 60/82 (73.2) 16/23 (69.6) 0.88
Atherosclerosis, no./total no. (%)† 98/513 (19.1) 82/406 (20.2) 10/83 (12.0) 6/24 (25.0) 0.16
Previous aortic dissection, no./total no. (%) 17/512 (3.3) 11/406 (2.7) 4/83 (4.8) 2/23 (8.7) 0.15
Previous aortic aneurysm, no./total no. (%) 60/513 (11.7) 52/407 (12.8) 5/82 (6.1) 3/24 (12.5) 0.21
Current smoking, no./total no. (%)‡ 36/120 (30.0) 28/89 (31.5) 7/27 (25.9) 1/4 (25.0) 0.85
Diabetes mellitus, no./total no. (%) 25/513 (4.9) 19/407 (4.7) 5/82 (6.1) 1/24 (4.2) 0.84
COPD, no./total no. (%) 6/140 (4.3) 3/106 (2.8) 3/30 (10.0) 0/4 (0.0) 0.26
Chronic renal insufficiency, no./total no. (%) 5/140 (3.6) 4/106 (3.8) 1/30 (3.3) 0/4 (0.0) 1.00
Previous invasive cardiac procedures
Open heart surgery, no./total no. (%) 44/499 (8.8) 33/396 (8.3) 8/81 (9.9) 3/22 (13.6) 0.53
Catheterization and/or PCI, no./
total no. (%)
32/409 (7.8) 25/326 (7.7) 6/65 (9.2) 1/18 (5.6) 0.86
Clinical presentation
Abrupt onset of pain, no./total no. (%) 439/498 (88.2) 350/395 (88.6) 67/79 (84.8) 22/24 (91.7) 0.60
Chest pain, no./total no. (%) 434/509 (85.3) 338/402 (84.1) 73/83 (88.0) 23/24 (95.8) 0.25
Migrating pain, no./total no. (%)§ 72/478 (15.1) 57/380 (15.0) 12/78 (15.4) 3/20 (15.0) 1.00
Hypotension/shock/tamponade, no./
total no. (%)¶
118/509 (23.2) 94/404 (23.3) 18/81 (22.2) 6/24 (25.0) 0.96
First systolic blood pressure (mm Hg),
meanSD
131.837.6 132.138.2 130.036.3 133.433.5 0.89
First diastolic blood pressure (mm Hg),
meanSD
73.022.0 72.921.8 72.723.9 74.719.3 0.93
Any pulse deficit, no./total no. (%)k 122/422 (28.9) 102/338 (30.2) 18/68 (26.5) 2/16 (12.5) 0.30
Any neurologic deficit, no./total no. (%)** 77/513 (15.0) 65/405 (16.0) 10/84 (11.9) 2/24 (8.3) 0.49
Abnormal ECG, no./total no. (%)†† 311/495 (62.8) 238/388 (61.3) 56/83 (67.5) 17/24 (70.8) 0.41
Diagnostic imaging
Number of studies per patient, meanSD 1.80.7 1.70.6 2.00.7 2.00.8 0.006
Computed tomography, no./total no. (%) 421/520 (81.0) 327/412 (79.4) 76/84 (90.5) 18/24 (75.0) 0.034
Magnetic resonance imaging, no./
total no. (%)
25/492 (5.1) 15/391 (3.8) 8/77 (10.4) 2/24 (8.3) 0.037
Trans-esophageal echocardiography, no./
total no. (%)
408/519 (78.6) 324/411 (78.8) 66/84 (78.6) 18/24 (75.0) 0.91
Arch vessel involvement, no./total no. (%)‡‡ 183/454 (40.3) 147/357 (41.2) 30/78 (38.5) 6/19 (31.6) 0.66
Widest diameter of ascending aorta (cm),
median (Q1 to Q3)§§
5.0 (4.4 to 5.8) 5.0 (4.4 to 5.6) 4.9 (4.1 to 6.0) 5.0 (4.1 to 6.1) 0.94
Widest diameter of descending aorta (cm),
median (Q1 to Q3)§§
3.3 (3.0 to 3.7) 3.2 (3.0 to 3.6) 3.5 (3.0 to 4.0) 3.4 (2.9 to 4.0) 0.51
Continued
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On univariate testing, age, preexisting renal failure and
aortic aneurysm, presenting with chest or back pain, and the
composite of postoperative cerebrovascular accident, coma,
or renal failure were significantly associated with death during
follow-up (Table 4). In the multiple regression models, only
age and the composite of postoperative cerebrovascular
accident, coma, or renal failure were statistically significant
(Table 5). The preoperative status of the false lumen did not
predict death after discharge in the univariate testing or when
adjusted for age and gender.
Table 1. Continued
All Patients (n=522)






Most distal extension of dissection
Ascending aorta, no./total no. (%) 59/392 (15.1) 47/310 (15.2) 10/66 (15.2) 2/16 (12.5) 1.00
Aortic arch, no./total no. (%) 80/392 (20.4) 53/310 (17.1) 21/66 (31.8) 6/16 (37.5) 0.005
Left subclavian level, no./total no. (%) 22/392 (5.6) 19/310 (6.1) 3/66 (4.5) 0/16 (0.0) 0.74
Descending thoracic aorta, no./total no. (%) 103/392 (26.3) 86/310 (27.7) 12/66 (18.2) 5/16 (31.2) 0.24
Abdominal aorta, no./total no. (%) 128/392 (32.7) 105/310 (33.9) 20/66 (30.3) 3/16 (18.8) 0.41
SD indicates standard deviation; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; ECG, echocardiogram; ANOVA, analysis of variance.
*Analyzed using ANOVA. Independent T-test between groups: Patent vs partial thrombosis, P=0.019. Patent vs complete thrombosis, P=0.026. Partial vs complete thrombosis, P=0.411.
†Any history of PCI, coronary artery bypass graft surgery, or catheterization demonstrating >70% stenosis in coronary, cerebral, or peripheral vasculature.
‡Tobacco use during the last month.
§Pain changed location.
¶Hypotension defined as systolic blood pressure <100 mm Hg.
kDiminution or absence of pulse in either right or left carotid, brachial or femoral arteries.
**Paraparesis, paraplegia, stroke, or coma.
††Showing signs of old or new infarction, nonspecific ST-T segment changes, left ventricular hypertrophy or low voltage.
‡‡Any imaging modality showing dissection extending into the brachiocephalic trunk, left common carotid artery or left subclavian artery.
§§Q1 to Q3 denotes interquartile range.
Table 2. Surgical Treatment and In-Hospital Complications
All Patients (n=522)







Complete arch replacement, no./total no. (%) 60/489 (12.3) 42/385 (10.9) 14/81 (17.3) 4/23 (17.4) 0.20
Descending aortic replacement, no./total no. (%)* 8/490 (1.6) 5/387 (1.3) 2/80 (2.5) 1/23 (4.3) 0.17
Aortic valve replacement, no./total no. (%) 145/485 (29.9) 124/384 (32.3) 16/78 (20.5) 5/23 (21.7) 0.080
Hypothermic circulatory arrest
HCA used, no./total no. (%) 430/500 (86.0) 342/393 (87.0) 69/84 (82.1) 19/23 (82.6) 0.39
HCA duration (minutes), median (Q1 to Q3)† 44 (28 to 97) 44 (28 to 100) 42 (25 to 80) 46 (33 to 87) 0.52
In-hospital complications (pre- and postoperative)
Neurologic deficit, no./total no. (%)‡ 125/501 (25.0) 98/397 (24.7) 21/81 (25.9) 6/23 (26.1) 0.98
Mesenteric ischemia or infarction, no./total no. (%) 16/496 (3.2) 15/393 (3.8) 1/80 (1.2) 0/23 (0.0) 0.57
Acute renal failure, no./total no. (%)§ 97/502 (19.3) 76/397 (19.1) 18/81 (22.2) 3/24 (12.5) 0.60
Limb ischemia, no./total no. (%) 67/499 (13.4) 55/395 (13.9) 11/80 (13.8) 1/24 (4.2) 0.48
HCA indicates hypothermic circulatory arrest.
*Replacement of at least part of the aorta between the left subclavian level and the diaphragm.
†Q1 to Q3 denotes interquartile range.
‡Stroke, coma, or spinal cord ischemia.
§Three-fold increase in serum creatinine, 75% reduction in glomerular filtration rate, serum creatinine ≥354 lmol/L, urine output <0.3 mL/kg per hour over 24 hours or anuria for
≥12 hours.
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The Kaplan–Meier curves showed an overall 5-year survival
of 84.7% (95% CI; 79.6% to 88.6%; Figure 2). The extent of
preoperative false lumen thrombosis did not affect the 5-year
survival rates (Figure 3). Nor did thrombosis of the false
lumen preoperatively affect freedom of major adverse events
(Figure 4).
Discussion
The data included in the present analysis reject the hypoth-
esis that a partially thrombosed false lumen on preoperative
imaging was a predictor of an ominous clinical course in
patients with surgically treated AAAD.
To our knowledge, the relationship between partial
thrombosis of the false lumen and long-term outcome in
patients with aortic dissection has been examined in 7
studies.13–15,17–20 All of these studies have included patients
with either type B dissections, postoperative AAAD, or a
combination of both. The results have been divergent. Partial
thrombosis was identified as an independent predictor for
aortic enlargement, aortic-related procedures, or death in 2
studies.13,14 In the remaining 5 studies,15,17–20 partial throm-
bosis was not associated with a worse outcome, faster aortic
growth, or higher incidence of aneurysm development com-
pared to complete patency of the false lumen. However, in the






Age 1.04 1.02 to 1.07 0.001
Age ≥70 years 2.96 1.65 to 5.31 <0.001
Female gender 1.24 0.66 to 2.35 0.51
Atherosclerosis* 1.48 0.78 to 2.82 0.23
Patent false lumen† 1.00
Partially thrombosed
false lumen
0.80 0.34 to 1.88 0.60
Completely thrombosed
false lumen
0.87 0.21 to 3.61 0.85
Postoperative CVA, coma
and/or acute renal failure‡
2.73 1.46 to 5.11 0.002
Postoperative spinal
cord ischemia
0.93 0.13 to 6.80 0.95
Presenting diameter
ascending aorta
1.02 0.80 to 1.31 0.86
Presenting diameter
descending aorta
1.20 0.77 to 1.87 0.42
Chronic renal insufficiency 7.00 1.40 to 34.87 0.018
Previous aortic aneurysm 2.31 1.15 to 4.66 0.019
Peripheral artery disease 6.23 0.75 to 51.88 0.091
Postoperative mesenteric
ischemia/infarction
5.66 0.77 to 41.77 0.089
Presenting syncope 0.50 0.20 to 1.27 0.14
Presenting CVA 1.87 0.67 to 5.23 0.23
Surgery on descending aorta 3.02 0.73 to 12.46 0.13
Presenting chest or back
pain
0.44 0.21 to 0.92 0.029
CVA indicates cerebrovascular accident.
*Any history of percutaneous coronary intervention, coronary artery bypass graft surgery
or catheterization demonstrating > 70% stenosis in coronary, cerebral or peripheral
vasculature.
†Patent false lumen is the reference group.
‡Three-fold increase in serum creatinine, 75% reduction in glomerular filtration rate,
serum creatinine ≥354 lmol/L, urine output <0.3 mL/kg per hour over 24 hours or
anuria for ≥12 hours.







Female gender 0.90 0.43 to 1.87 0.78
Age ≥70 years 2.34 1.20 to 4.56 0.012
Patent false lumen* 1.00
Partial thrombosis
false lumen
0.78 0.30 to 1.99 0.60
Complete thrombosis
false lumen
0.81 0.19 to 3.44 0.78
Postoperative CVA, coma
and/or renal failure†
2.62 1.40 to 4.92 0.003
CVA indicates cerebrovascular accident.
*Patent false lumen is the reference group.
†Three-fold increase in serum creatinine, 75% reduction in glomerular filtration rate,
serum creatinine ≥354 lmol/L, urine output <0.3 mL/kg per hour over 24 hours or
anuria for ≥12 hours.
Table 3. Aortic Growth Rates (mm/year).
All Patients (n=522)
Status of the False Lumen
P ValuePatent (n=414) Partial Thrombosis (n=84) Complete Thrombosis (n=24)
Aortic arch, median (Q1 to Q3) 0.5 (0.3 to 2.0) 0.5 (0.5 to 1.8) 1.7 (0.0 to 4.2) 0.3 (1.0 to 9.2) 0.24
Descending thoracic aorta,
median (Q1 to Q3)
2.0 (0.2 to 4.0) 1.8 (0.4 to 4.0) 2.1 (0.1 to 4.9) 0.3 (0.5 to 3.4) 0.29
Q1 to Q3 denotes interquartile range.
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study by Sueyoshi et al,15 which compared aortic enlarge-
ment across different degrees of false lumen thrombosis in
type B dissections, a subset within the partial thrombosis
group with a blind pouch in the false lumen (ie, thrombosis
covering the potential reentry site) had considerably faster
growth rates. This group was small, only accounting for 15% of
the patients with partial thrombosis of the false lumen.
Results from previous studies on type B dissections and
postoperative AAAD cannot readily be extrapolated to our data,
as we examined the influence of preoperative false lumen
thrombosis in AAAD. In addition, the fact that partial throm-
bosis of the false lumen seems to be unfavorable in type B
dissections does not necessarily imply that this is the case in
postoperative AAAD. The notion that an operated AAAD with a
persistent false lumen in the descending aorta mirrors a type B
dissection is not intuitive. In AAAD, the primary entry tear is
typically located in the ascending aorta, whereas the area just
distal to the subclavian artery is the predilection site in type B
dissections.21,22 This region is also most prone to dilation and
rupture in the chronic phase.20 By surgically removing the
primary entry tear, the pathological process of an AAAD is
fundamentally changed. Residual intimal tears, which maintain
flow in the false lumen and remain distal after type A dissection
repair, might have a different impact on flow and pressure
dynamics compared to that associated with the primary entry
in type B dissections. In fact, a residual primary entry tear
independently predicts the need for reintervention in patients
with operated AAAD only.17 Moreover, patients with a patent
false lumen distally to AAAD repair have better outcomes
compared to type B dissections, which is potentially related to
the size and location of intimal tears.23 It is also to be noted,
that the one study supporting partial thrombosis as a negative
predictor in surgically treated AAAD14 is based on 27 patients
with a particularly high mortality of 60% at 5 years.
We observed that the degree of false lumen thrombosis
appeared to increase with age. It is unknown why older
Figure 3. Kaplan–Meier postdischarge survival curves stratified
according to the false lumen status.
Figure 2. Kaplan–Meier postdischarge survival curve for all
patients.
Figure 4. Kaplan–Meier curves of postdischarge freedom from
major adverse events (all-cause mortality, aortic rupture and
reoperation, including endovascular repair), stratified according to
the false lumen status.
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patients are more likely to have spontaneous complete
thrombosis of the false lumen, but blood coagulability
increases with age.24 The group with complete thrombosis
was small: 24 patients (4.6% of the total patient cohort).
Traditionally, complete thrombosis of the false lumen has
been thought to be a prerequisite for healing of the aorta
postdissection, as flow and pressurization of the false lumen
are thought to contribute to late dilation and rupture.
Accordingly, one could expect lower mortality during follow-up
in this setting. Our data did not show that there was any
survival benefit associated with complete false lumen throm-
bosis. Because of the small number of patients, even in the
IRAD database, adjusted comparisons with this group lacked
statistical power. Of great practical importance, however, is
that there are no definitive clinical epidemiological data
supporting the traditional view that a persistent blood-flow in
the false lumen is a definitive negative predictor for outome.25
Thus, an extensive procedure with arch replacement and
intraoperative stentgrafting of the descending aorta3,4 has
little support as a routine procedure in AAAD. Such an
extensive operation is also at odds with the acceptable overall
long-term survival rate of 85% at 5 years in surgically treated
AAAD in the IRAD database.
The imaging characteristics in our material warrant further
attention. Patients with partial or complete thrombosis of the
false lumen were subjected to more imaging studies com-
pared to those with no thrombosis of the false lumen. It could
be argued that partial or complete thrombosis of the false
lumen is more likely to be diagnosed with an increasing
number of different imaging modalities and that a given
portion of the patients who were categorized as having patent
lumens may have actually had some degree of thrombosis.
Conversely, diagnosing aortic dissection itself can be chal-
lenging, more so when there is no flow in the false lumen. In
the case of a “classic” aortic dissection with flow in the false
lumen and a clearly visible intimal flap, the diagnosis is
straightforward. When the false lumen is void of flow,
establishing the diagnosis can be difficult, particularly by
echocardiography. Additional imaging is required in such
circumstances.
A key aspect in the interpretation of our data is that the
status of the false lumen was established once (at presen-
tation, ie, before surgery). The main goal of surgery in AAAD is
to prevent lethal complications, such as rupture, cardiac
tamponade, and malperfusion. A secondary goal is to resect
the entry tear and redirect the blood flow to the true lumen.
Resection of the primary tear and aortic reconstruction will
alter flow in the false lumen and might promote thrombosis.
Thus, our classification (based on aortic morphology at
presentation), may be altered postoperatively. However, a
distal false lumen remains patent in as many as 79% of
patients following the initial repair.9,10,26–29
Strengths and Limitations of the Study
The main strength of the study is that it included >500
patients in an orderly, prespecified manner during a limited
time period. However, IRAD is an observational registry and
selection bias is possible. Furthermore, follow-up data were
not available for more than half of the survivors. As a result,
our data might not be representative of the entire IRAD
patient population but might represent a selection from the
centers with the most systematic patient registration and
follow-up.
Information on preoperative false lumen status was lacking
for 40% of the AAAD patients in IRAD. In cases of iatrogenic
dissections that occur during elective or emergency cardiac
surgery for other reasons, preoperative imaging will not be
relevant. Also, when a patient with AAAD present with cardiac
tamponade, cardiac arrest, or other critical conditions,
preoperative imaging will in many cases be limited to a
screening echocardiography, and details regarding false
lumen thrombosis will not be available.
Imaging techniques may have varied among the centers.
Misclassification of false lumen status was possible as the
imaging data were collected and reviewed at each participating
center before the start of the study and were not reevaluated
in a core laboratory. Likewise, patients with a completely
thrombosed false lumen might have been excluded and
patients with an intramural hematoma might have been
included, as this distinction can be challenging. Furthermore,
traditional first-pass imaging of the aorta might have overes-
timated the degree of thrombosis in the false lumen.30
We were unable to provide cause-of-death data and the
distribution of aortic-related and nonaortic-related death
could be different between the groups.
Conclusions
The present study revealed that preoperative partial throm-
bosis of the false lumen in surgically treated AAAD in the IRAD
database was not an independent risk factor for aortic
enlargement, intervention, or death in the follow-up period.
The AAAD survivors had favorable prognoses, but the factors
that influence aortic dilation and rupture following acute aortic
dissections are still incompletely understood. New imaging
techniques, for example, based on flow-dynamics31 and/or
bioimaging32,33 can hopefully improve our ability to predict an
ominous outcome in patients with aortic dissection.
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